If they do raise again, that will be the third time in
a row where management have claimed there
would be no more CRs and then gone ahead
and raised. The dishonesty in fledgling bio techs
is scandalous in this country and should be
regarded as criminal behaviour IMO.
Ann: Preliminary results of further XPERIENCE studies released, page-10
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $65.63M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 23.5¢ | 21.5¢ | $160.4K | 720.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3163 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| NXS (ASX) Chart |